valdecoxib has been researched along with Liver Dysfunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alsalameh, S; Burian, M; Geisslinger, G; Mahr, G; Woodcock, BG | 1 |
| Britto, MR; Mainka, MB; Parivar, K; Sarapa, N | 1 |
1 review(s) available for valdecoxib and Liver Dysfunction
| Article | Year |
|---|---|
Review article: The pharmacological properties and clinical use of valdecoxib, a new cyclo-oxygenase-2-selective inhibitor.
Topics: Adult; Aged; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Biological Availability; Bone Diseases; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Interactions; Dysmenorrhea; Female; Humans; Isoenzymes; Isoxazoles; Liver Diseases; Male; Membrane Proteins; Middle Aged; Mouth Diseases; Osteoarthritis; Pain; Prostaglandin-Endoperoxide Synthases; Rats; Sulfonamides | 2003 |
1 trial(s) available for valdecoxib and Liver Dysfunction
| Article | Year |
|---|---|
The effect of mild and moderate hepatic impairment on the pharmacokinetics of valdecoxib, a selective COX-2 inhibitor.
Topics: Adult; Aged; Area Under Curve; Cyclooxygenase 2 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Female; Half-Life; Humans; Isoxazoles; Lidocaine; Liver Diseases; Male; Matched-Pair Analysis; Metabolic Clearance Rate; Middle Aged; Sulfonamides | 2005 |